According to Diabetes UK (which is run by the British Diabetic Association), diabetic people have a 30 times higher risk of amputation than the general population. A huge number of amputation surgeries are performed each year as a result of this high possibility, necessitating adequate wound dressing to prevent post-surgery infections. Active, passive, and interactive wound dressings are the three types of wound dressings available. Active wound dressings encourage healing by creating a moist wound environment, whereas passive wound dressings just protect the wound. As a result, demand for sophisticated wound dressings such as hydrogels and foams is likely to rise.
Interactive dressings help Wound Dressing Market healing by creating a moist wound environment and interacting with wound bed components. Because wound dressings like hydrogels and alginates are permeable and non-occlusive, they require a secondary dressing. Composite multi-layer dressings are affordable and can be used for both primary and secondary wound treatment. The need for sophisticated wound dressings is projected to boost the worldwide wound dressing market.
The worldwide wound dressing market is predicted to develop as the patient pool grows.
Diabetic foot ulcers afflict around 1% to 4% of the diabetic population in the United States each year, according to the American Diabetes Association (ADA). Furthermore, according to Diabetes UK, the prevalence of diabetic foot ulcers in diabetic individuals is predicted to be 2.5 percent or roughly 86,000 people in the United Kingdom in 2015. Furthermore, according to the same source, approximately 7,400 leg, foot, or toe amputation procedures are performed in England each year.
Restraints on the Wound Dressing Market
Product recalls, the availability of alternative products, and the high cost of the Wound Dressing Market are all likely to stymie the global wound dressing market's growth over the forecast period. Product failure, component inconsistencies, and packaging issues are all contributing to an increase in product recalls. For example, in August 2018, the US Food and Drug Administration (FDA) issued a product recall for Safe N Simple, LLC's Simpurity Hydrogel Absorbent Sheet wound dressing because the sterilizing technique was used on the dressing equipment was not FDA-approved. It is possible that the product's quality will decline with time.
Competitive Landscape of the Wound Dressing Market
3M Company, Coloplast A/S, Derma Sciences, Inc., Smith & Nephew Plc, Mölnlycke Healthcare, Medtronic Plc, Medline Industries, Inc., Organogenesis Inc., Integra LifeSciences Corporation, and MiMedx Group, Inc. are some of the major competitors in the worldwide wound dressing market.
0 Comments